| How has proteomics informed transfusion biology so far? | |
| | |
MedLine Citation:
|
PMID: 20117018 Owner: NLM Status: In-Process |
Abstract/OtherAbstract:
|
Since the genomic era has not fully kept its promises, studies addressing the protein complement to the genome have been recently gaining momentum. Proteomics investigations could be potentially used from bench to bedside, in order to test the quality of collected blood components prior to or during storage. In parallel, proteomics could be used to verify the effects of the production and pathogen reduction processes of plasma derivatives and blood components on the protein fractions, or to reduce the effects of storage lesions. Another area of interest is represented by the discovery of peculiar biomarkers readily adoptable for targeted evaluation of blood-component integrity or functionality, as well as to assess the proliferative capacity of hematopoietic stem/progenitor cells. These accumulating basic research evidences will hopefully be accompanied by actual applications in routine clinical practice. Whether the costs of the needed facilities (instruments and trained personnel) will meet the current demand of the clinical market, proteomic-expert transfusionists will no longer only inform, but also perform a role in clinical routine. |
| | |
Authors:
|
Giancarlo Liumbruno; Angelo D'Alessandro; Giuliano Grazzini; Lello Zolla |
Related Documents
:
|
11087168 - Efforts in minimizing risk of viral transmission through viral inactivation. 3628078 - Degradation and aggregation of delta sleep-inducing peptide (dsip) and two analogs in p... 11686288 - Validation of blood product irradiation doses. 22178028 - Circulating levels of metals are related to carotid atherosclerosis in elderly. 3485858 - Selective iga deficiency in japanese blood donors: frequency and statistical analysis. 6155788 - Prostacyclin inhibits pancreatic secretion. |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-02-08 |
Journal Detail:
|
Title: Critical reviews in oncology/hematology Volume: 76 ISSN: 1879-0461 ISO Abbreviation: Crit. Rev. Oncol. Hematol. Publication Date: 2010 Dec |
Date Detail:
|
Created Date: 2010-11-08 Completed Date: - Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8916049 Medline TA: Crit Rev Oncol Hematol Country: Netherlands |
Other Details:
|
Languages: eng Pagination: 153-72 Citation Subset: IM |
Copyright Information:
|
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved. |
Affiliation:
|
Italian National Blood Centre, Istituto Superiore di Sanità, Rome, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Influence of 670nm low-level laser therapy on mast cells and vascular response of cutaneous injuries...
Next Document: Employment and work-related issues in cancer survivors.